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Objectives: The aim of the investigation was to use in vitro transposon mutagenesis to generate
metronidazole resistance in the obligately anaerobic pathogenic bacterium Bacteroides thetaiotaomicron,
and to identify the genes involved to enable investigation of potential mechanisms for the generation of
metronidazole resistance.
Methods: The genes affected by the transposon insertion were identiﬁed by plasmid rescue and
sequencing. Expression levels of the relevant genes were determined by semi-quantitative RNA hybrid-
ization and catabolic activity by lactate dehydrogenase/pyruvate oxidoreductase assays.
Results: A metronidazole-resistant mutant was isolated and the transposon insertion site was identiﬁed in
an intergenic region between the rhaO and rhaR genes of the gene cluster involved in the uptake and cata-
bolism of rhamnose. Metronidazole resistance was observed during growth in deﬁned medium containing
either rhamnose or glucose. The metronidazole-resistant mutant showed improved growth in the presence
of rhamnose as compared with the wild-type parent. There was increased transcription of all genes of the
rhamnose gene cluster in the presence of rhamnose and glucose, likely due to the transposon providing
an additional promoter for the rhaR gene, encoding the positive transcriptional regulator of the rhamnose
operon. The B. thetaiotaomicron metronidazole resistance phenotype was recreated by overexpressing the
rhaR gene in the B. thetaiotaomicron wild-type parent. Both the metronidazole-resistant transposon
mutant and RhaR overexpression strains displayed a phenotype of higher lactate dehydrogenase and
lower pyruvate oxidoreductase activity in comparison with the parent strain during growth in rhamnose.
Conclusions: These data indicate that overexpression of the rhaR gene generates metronidazole
resistance in B. thetaiotaomicron
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Introduction
Bacteroides fragilis and Bacteroides thetaiotaomicron are
members of the normal resident gastrointestinal microbiota, and
are important opportunistic pathogens that are capable of
causing life-threatening infections such as peritonitis, serious
gynaecological sepsis, bacteraemia, and soft tissue and
brain abscesses.
1,2 Metronidazole [1-(2-hydroxyethyl)-2-
methyl-5-nitroimidazole] is commonly used in the treatment of
these anaerobic microbial infections. In addition, it is used for
routine prophylaxis during gastrointestinal tract and gynaecolo-
gical surgery. It is administered as an inert prodrug that is acti-
vated intracellularly under anaerobic conditions by the reduction
of its nitro group. This generates an active toxic derivative,
which causes single- and double-strand DNA breaks.
3 In certain
anaerobic protozoa, activation of metronidazole involves a low
intracellular redox potential process that results in the reduction
of the 5-nitro group forming the transient toxic radicals.
4 The
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short-lived cytotoxic intermediates, acetamide and N-(2-hydro-
xyethyl)-oxamic acid.
5–7 Activation of the drug is likely to
occur through interaction with a pyruvate oxidoreductase
complex in an ATP-dependent reaction.
4,8 The pyruvate oxido-
reductase complex is formed by a metabolic reaction between
pyruvate and the oxidoreductase enzyme to facilitate pyruvate
decarboxylation to form acetyl CoA. This reaction generates
electrons that are accepted by ferredoxins or ﬂavodoxins that
have electron efﬁciency of 2430 or 2460 mV.
5 Studies on
several B. fragilis species suggest that metronidazole activation
occurs at a similar pyruvate oxidoreductase complex.
8–10
Bacteroides spp. can develop resistance to metronidazole via
acquisition of nitroimidazole resistance genes (nim) that may be
encoded on mobile genetic elements (reviewed by Patrick
11).
These encode a reductase that converts the nitro group of metro-
nidazole into an amine, thus rendering it inactive.
3
Overexpression of efﬂux pumps is known to play a role in the
resistance of Bacteroides spp. to a range of antibiotics.
1 While this
may also confer resistance to metronidazole, efﬂux pump inhibi-
tors did not restore metronidazole susceptibility in a multiresistant
B. fragilis that lacked nim genes,
12 suggesting that there are
alternative mechanisms of resistance. In this study, we report the
isolation and characterization of a B. thetaiotaomicron metronida-
zole-resistant mutant. We demonstrate for the ﬁrst time a link
between metronidazole resistance, the rhamnose catabolic pathway
and the pyruvate oxidoreductase complex, and the overexpression
of the regulator of the rhamnose catabolic pathway, RhaR.
Methods
Bacterial cultivation, strains and plasmids
The bacterial strains and plasmids used in this study are listed in
Table 1.
B. thetaiotaomicron cultures were grown anaerobically in brain
heart infusion broth supplemented with haemin, menadione and
cysteine (BHIS) or BHIS agar (1.5% w/v)
13 as previously
described.
14 Escherichia coli strains were grown with aeration in
Luria-Bertani (LB) broth
15 or on LB agar plates (1.5% w/v) at
378C. The antibiotics gentamicin (200 mg/L), ampicillin (100 mg/L),
tetracycline (2 mg/L) and erythromycin (10 mg/L) were added
to BHIS or LB whenever necessary. E. coli strains carrying
plasmids were grown in LB medium supplemented with ampicillin
(100 mg/L). Carbohydrate utilization studies were performed by
growing B. thetaiotaomicron in deﬁned medium (DM)
16 sup-
plemented with 0.1% of either glucose (DMG) or rhamnose (DMR)
(Sigma-Aldrich) as the sole carbon source. Growth of the organisms
was measured as an increase in optical density at 600 nm (OD600)
over time. Metronidazole survival studies were performed by
growing B. thetaiotaomicron cultures to mid-exponential phase in
DMR or DMG broth followed by exposure to 15 mg/L metronida-
zole. Viable counts were determined anaerobically at various time-
points by plating culture dilutions in triplicate on BHIS agar plates
and incubation at 378C for 72 h.
Tn44000 transposon mutagenesis, Southern hybridization
and identiﬁcation of the transposon insertion site
The construction of a B. thetaiotaomicron VPI-5482 transposon
mutant library was carried out using the transposon delivery vector,
pYT646B, and the conjugation mutagenesis method of Tang and
Malamy.
17 Selection of the transconjugant colonies was performed
anaerobically by plating the conjugation mixture onto BHIS agar
plates containing gentamicin and either tetracycline or erythromycin.
Plasmid rescue was carried out according to Chen et al.
18 Putative
metronidazole-resistant mutants were screened on BHIS agar plates
containing metronidazole ranging in concentration from 0.5 to 8 mg/L.
The mutant B. thetaiotaomicron Tn Met
R was selected for further
study. Southern blot analysis was performed according to standard pro-
tocols
15 using genomic DNA (20 mg) of both B. thetaiotaomicron
VPI-5482 and the B. thetaiotaomicron Tn Met
R mutant, as well as
Table 1. Bacterial strains and plasmids
Strain or plasmid Relevant characteristics
Source or
reference
Strains
B. thetaiotaomicron
VPI-5482 clinical isolate: wild-type ATCC 29148
Tn Met
R VPI-5482 containing the Tn44000 transposon from pYT646B; (Tc
r) this study
rhaR
(þ) VPI-5482 containing rhaR gene on pLYLrhaR in cytoplasm; (Tc
r) this study
E. coli
DH5a F
2 end A1 hsdR17(rk
2 mk
þ) supE44 thi-l mutant recA1 gyrA96 relA1D(argF-lacZYA)U169
F80dlacZM15
15
S17-1 contains the transfer functions of RP4 integrated in the chromosome; recA Tp
r TraRP4 37
Plasmids
pYT646B delivery vector carrying Tn44000 transposon 17
pLYL01 2.6 kb SstI fragment containing the tetQ gene from pNFD13-2 cloned into the AatII site of
pFD160R; Ap
r (Tc
r) Mob
22
pLYLrhaR pLYL01 containing rhaR and 239 bp upstream of rhaR;A p
r (Tc
r) Mob 14
Tc
r, tetracycline-resistant; Ap
r, ampicillin-resistant; Tp
r, trimethoprim-resistant; Mob, mobilization region on plasmid.
Parentheses around the antibiotic resistance phenotype indicate that it is expressed only in E. coli. If there are no parentheses, then the antibiotic resistance
phenotype is expressed in B. thetaiotaomicron only.
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26820 ng of the 13.1 kb transposon delivery vector, pYT646B,
each digested to completion with restriction enzyme PvuII.
15
B. thetaiotaomicron total genomic DNA was prepared according to
the method of Wehnert et al.
19 and E. coli plasmid DNA was pre-
pared by the alkali-hydrolysis method of Ish-Horowicz and Burke.
20
The DNA probe used for hybridization was a 0.9 kb internal frag-
ment of the pYT646B tetQ gene generated by digesting it with SacI
and EcoRI. Hybridization and detection procedures were performed
according to the manufacturers’ instructions. For identiﬁcation of
the transposon insertion site, genomic DNA from the mutant was
digested with HindIII and the fragment adjacent to the transposon
was isolated by plasmid rescue.
18 The chromosomal DNA in the
resulting ampicillin-resistant plasmid was sequenced using primer
L58, derived from IS4400R in the transposon.
18 The primers listed
in Table 2 were used to amplify the 50 and 30 junction ends of the
transposon insertion in the B. thetaiotaomicron Tn met
R chromoso-
mal DNA. The PCR fragments obtained were puriﬁed using the
High Pure PCR Cleanup Kit (Roche) and sequenced as previously
described.
14 B. thetaiotaomicron VPI-5482 sequence data were
obtained from the NCBI website (GenBank accession number
NC_004663). Analysis was done using the BLAST algorithm
21 and
DNAMAN software V4.13.
RNA extraction and semi-quantitative dot blot hybridization
B. thetaiotaomicron wild-type and mutant cells for RNA extraction
were grown anaerobically to late exponential phase in DMR or DMG
and the total RNA was isolated.
14 RNA was treated with DNaseI and
quantiﬁed using the NanoDrop
w ND-100 spectrophotometer
(NanoDrop Technologies, Inc.). For semi-quantitative RNA hybridi-
zation studies, equal amounts (1 mg) of the B. thetaiotaomicron
RNA were spotted in equal volumes (2 mL) onto a nylon membrane
(Roche). Hybridization and detection procedures were performed
according to the manufacturer’s instructions (Roche). Internal
fragments of the genes of interest were used as DNA probes for
transcriptional hybridization studies. These were prepared by PCR
ampliﬁcation using gene-speciﬁc primers (Table 2). The 16S rRNA
gene of B. thetaiotaomicron VPI-5482 was used as an internal
control (Table 2). The PCR, DNA hybridization, detection pro-
cedures and analysis were carried out as previously described by
Patel et al.
14 Signal intensities were measured using a densitometer
and analysed with GeneSnap 6.05 software (Synoptics Ltd). Results
from duplicate experiments were expressed as the ratio of the
gene-speciﬁc transcription signal of mutant cells as compared with
wild-type cells (induction ratio).
Construction of B. thetaiotaomicron rhaR overexpresser
strain
The full-length rhaR gene, including 239 bp upstream of the gene,
was PCR ampliﬁed using primers cRF and cRR (Table 2). The PCR
product was digested with HindIII and XmnI, cloned into the
HindIII and SmaI sites of the shuttle vector pLYL01
22 and trans-
formed into E. coli DH5a. The resultant plasmid, pLYLrhaR, was
extracted, puriﬁed and retransformed into E. coli S17-1 according to
standard methods.
15 Mobilization of pLYLrhaR from E. coli S17-1
(pLYLrhaR) into B. thetaiotaomicron VPI-5482 was performed by
the conjugation procedure of Li et al.
22 The resulting transconju-
gant, B. thetaiotaomicron rhaR
(þ), was grown on BHIS agar with
tetracycline (2 mg/L).
Preparation of cell-free extracts (CFEs) and enzyme assays
B. thetaiotaomicron VPI-5482 cultures for CFEs were grown anae-
robically to late log phase in DMR broth. Cells were harvested by
centrifugation (8 K, 48C, 10 min). Pellets were washed three times
under anaerobic conditions in 10 mM Tris–HCl, pH 8.0 (for the
lactate dehydrogenase assay) or 10 mM phosphate buffer with
250 mM b-mercaptoethanol, pH 7.0 (for the pyruvate oxidoreduc-
tase assay), and resuspended in 5 mL of the same buffers,
Table 2. Oligonucleotides used for PCR
Designation 50–30 sequence Use Source or reference
L58 CAA TAA TGG ACC TCG TAA AAG Tn junction PCR and plasmid rescue 17
TnOF AAT CGT ACA TTC CAT GGC Tn junction PCR this study
TnRR ACC GAA TTT GCG GTC TCC AT Tn junction PCR this study
Primer c TAG CAA ACT TTATCC ATT CAG Tn junction PCR 18
iKF CCGTTATCTAAGCGGTGCC DNA probe rhaK 14
iKR CCGAAATTCTCTTCTTGCAGT DNA probe rhaK 14
iIF GCAATATTGATGAACTGCGTGCC DNA probe rhaI 14
iIR GATTTCTGCAATGAAATCTTCGC DNA probe rhaI 14
iPF GAAAATCGTCCGGCACTTGCC DNA probe rhaP 14
iPR TCATACCATCCGCTTCGAAGC DNA probe rhaP 14
iAF TATAGCCATCGGTAGCTTTTGCC DNA probe rhaA 14
iAR ATTACTAAAGGTTACGTTCAGCGCC DNA probe rhaA 14
iOF CTTATTTCGGTGCAGGATGCC DNA probe fucO 14
iOR CGAACATATCGCTCATAGCCC DNA probe fucO 14
iRF GCTGAAGGAGCATCC GTC DNA probe rhaR 14
iRR GTCTCATCGCCAGTTCCTCC DNA probe rhaR 14
16SF AGAGTTTGATCTTGGCTCAG DNA probe 16S rRNA 14
16SR ACGGTTACCTTGTTACGACTT DNA probe 16S rRNA 14
CRF GTGAGGAAGAGGATTCTCCGG rhaR in pLYL01 14
cRR ACAGATTTAAACGGAAAGCTTAAACTACATCG rhaR in pLYL01 14
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269respectively. Cells were disrupted by sonication using an MSE soni-
cator at an amplitude of 18–24 mm for periods of 30 s/mL of cell
suspension in tubes chilled at 08C. Cell debris was removed by cen-
trifugation (8 K, 48C, 20 min). The supernatant was collected (CFE)
and protein concentrations were determined using Bio-Rad reagents
according to the manufacturer’s instructions (Bio-Rad Laboratories).
Lactate dehydrogenase activity was measured anaerobically at 378C
by the rate of decrease in absorbance of NADH at a wavelength of
340 nm using a Beckman DU
w530 Lifescience UV/Vis
Spectrophotometer according to the method of Abbe et al.
23 Enzyme
activity was recorded as mM NADH/mg of protein/min at 340 nm.
Pyruvate oxidoreductase activity was measured spectrophotometri-
cally at an absorbance of 600 nm using a Beckman DU
w530
Lifescience UV/Vis Spectrophotometer, with methyl viologen as the
electron acceptor at 378C under anaerobic conditions using the
method of Lindmark and Mu ¨ller.
24 The enzyme activity was recorded
as mM methyl viologen/mg of protein/min at 600 nm. All the
experiments were performed in triplicate.
Results and discussion
Isolation of the metronidazole-resistant B. thetaiotaomicron
mutant
Transposon mutagenesis was used to create metronidazole-
resistant B. thetaiotaomicron mutants.
17 Tetracycline-resistant
transconjugants were detected at frequencies of 2 10
26 to
4 10
25 per E. coli donor cell. An average of 40% of
tetracycline-resistant transconjugants were co-integrates, com-
pared with the 4% co-integrate formation in B. fragilis reported by
Tang and Malamy.
17 The B. thetaiotaomicron transposon mutant
bank ( 2000 isolates) was screened for metronidazole resistance
on BHIS agar using metronidazole concentrations varying from
0.5 to 8 mg/L. A mutant, B. thetaiotaomicron Tn Met
R,w a si s o -
lated with an MIC of 8 mg/L metronidazole compared with the
wild-type, which had an MIC of 0.8 mg/L.
Location of the transposon insertion
Southern hybridization conﬁrmed the presence of a single trans-
poson insertion within the chromosome of the B. thetaiotaomicron
Tn Met
R mutant (data not shown). Plasmid rescue and junction
PCR of the chromosomal DNA were performed in order to
determine the precise location of the transposon within the
mutant. The transposon insertion was found to be 141 bp upstream
of rhaR, the gene encoding the positive transcriptional regulator
of rhamnose catabolism in B. thetaiotaomicron (Figure 1a and b).
We have demonstrated previously that this region contains the
rhaR gene promoter sequence.
14
Growth studies under inducing conditions
Growth studies were performed in order to investigate the
effect of L-rhamnose or D-glucose on the growth of the
metronidazole-resistant mutant. Results indicated that the mutant
strain grown in DMR attained a higher cell density after 10 h
when compared with the parent strain, with OD600 values of
1.00+0.02 and 0.65+0.03, respectively. There was no signiﬁ-
cant difference in the cell density of the wild-type and mutant
when cells were grown in DMG. This observation suggested
that the transposon was improving the capacity of the cells to
utilize rhamnose, possibly through increasing the levels of
RhaR, the positive transcriptional regulator. The transposon did
not, however, appear to affect the catabolism of glucose in the
mutant cells.
Effect of the transposon on transcription
The levels of transcription of the genes of the rhamnose cluster
were examined to determine if this was related to the enhanced
growth of the Met
R mutant when compared with the wild-type.
Semi-quantitative transcriptional dot blot hybridization studies
were performed using RNA extracted from cells grown in DMR
or DMG. Results indicated that the transposon insertion in the
intergenic region upstream of rhaR caused increased transcrip-
tion of all the rhamnose genes in B. thetaiotaomicron Tn Met
R
as compared with the wild-type strain. In the presence of rham-
nose, the genes rhaKIPAOR all showed an increase in transcrip-
tion, expressed as induction ratios of mutant versus wild-type, of
3.4, 3.8, 3.4, 4.4, 3.4 and 1.7, respectively. During growth in
glucose, an increase in transcription of these genes was also
seen, with induction ratios of 11.1, 19.5, 14.4, 18.8, 15.5 and
1.5, respectively. The internal control 16S rRNA gene was tran-
scribed at the same level in both wild-type and mutant strains
Figure 1. Genomic arrangement of the rhamnose gene cluster in B. thetaiotaomicron VPI-5482 (accession number NC 004663) and the B. thetaiotaomicron
Tn Met
R metronidazole-resistant mutant. (a) Position of the transposon insertion site. PKIAPO and PR indicate the two promoters that have been identiﬁed
using sequencing and bioinformatic analysis.
14 The dashed arrow shows the position of the Tn44000 transposon insertion. (b) Schematic representation (not to
scale) of the transposon insertion between rhaO and rhaR.I S 4400L and IS4400R, insertion sequence elements; arrows indicate positions of primers used to
conﬁrm the insertion site (Table 2); tetQ, gene expressing tetracycline resistance in Bacteroides species; bla, gene expressing b-lactamase (ampicillin
resistance) in E. coli; rhaO and rhaR, chromosomal genes of B. thetaiotaomicron VPI-5482.
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tively low level of increase in transcription of the positive regu-
lator, RhaR, can bring about higher levels of transcription of all
the genes of the rhamnose operon, even in the absence of rham-
nose. In the presence of rhamnose, increased transcription
resulted in improved utilization of the substrate and hence better
growth as compared with the wild-type parent. During growth in
glucose, the increased transcription of the rhamnose catabolic
genes brought no additional nutrient beneﬁt to the mutant cells
and the same growth response as the wild-type was observed.
Based on the location of the transposon and the orientation of
IS4400L relative to the transcriptional direction of rhaR
(Figure 1b), it is possible that the IS element could be acting as
an additional promoter leading to increased transcription. Figure 2
illustrates the DNA sequence obtained from sequence analysis of
the transposon insertion site relative to the rhaR promoter region
and coding sequence. Three possible typical Bacteroides putative
27 hexamers (consensus TAnnTTTG) were identiﬁed within the
IS4400L sequence. This is in keeping with the ﬁndings of Bayley
et al.
25 who ﬁrst described the B. fragilis consensus promoter and
reported its presence in the IS4351 element, which is identical to
IS4400 used in this study. It is not unusual for IS elements to act
as strong promoters and activate genes
26,27 and their role in natu-
rally occurring antibiotic resistance is well documented. For
example, Haggoud et al.
28 ﬁrst identiﬁed the IS1168 insertion
sequence as being located upstream of the nitroimidazole resist-
ance genes (nim), and Soki et al.
29 reported that nine nimA genes
were activated by IS1168 and three of the nimC genes were acti-
vated by IS1170.I nB. fragilis, Rogers et al.
30 associated the
IS1224 insertion upstream of the cepA b-lactamase gene with
up-regulation and Podglajen et al.
31 reported that IS1186 activated
the expression of the metallo-b-lactamase cﬁA gene, causing
resistance to carbapenems. They later identiﬁed the typical
Bacteroides consensus promoter sequences within two IS
elements, IS1187 and IS1188, that were found upstream of cﬁA.
32
Based on the analysis of the IS4400L in relation to RhaR, it is
likely that these consensus promoter elements within the IS4400
element are increasing the activation of the rhaR gene, as
observed in the transcriptional studies.
Metronidazole resistance
The transposon insertion in the intergenic region between
rhaO and rhaR was shown to increase the transcription of the
rhamnose genes in B. thetaiotaomicron Tn Met
R. It was, there-
fore, possible that higher levels of RhaR were causing the metro-
nidazole resistance phenotype. In order to test this hypothesis,
RhaR, the positive transcriptional regulator of the rhamnose
operon,
14 with its putative promoter region, was overexpressed
in B. thetaiotaomicron VPI-5482 through introducing the rhaR
gene into the parent strain on a multicopy plasmid to create
B. thetaiotaomicron rhaR
(þ). Overexpression of the rhamnose
genes in this strain was tested at the transcriptional level in
deﬁned medium supplemented with rhamnose, and the results
indicated that overexpression of the RhaR protein resulted in
increased transcription of these genes (data not shown). In order
to test the metronidazole resistance phenotype, cells grown in
deﬁned medium supplemented with rhamnose or glucose were
exposed to 15 mg/L metronidazole for 40 min. Results showed
that the log10 of the surviving fractions of the B. thetaiotaomicron
Tn Met
R mutant and B. thetaiotaomicron rhaR
(þ), grown in
DMR, were 21.65 (+0.007) and 21.88 (+0.010), respectively.
These were more resistant than the parent strain, which had
a log10 surviving fraction of only 22.78 (+0.001). The
B. thetaiotaomicron Tn Met
R mutant cells grown in DMG also
showed metronidazole resistance relative to the parental strain,
with the log surviving fractions of the mutant and wild-type
being 21.75 (+0.013) and 22.62 (+0.001), respectively. This
result supports the previously observed metronidazole resistance
during isolation of the mutant on BHIS agar, a glucose-
containing medium. These data represent the mean values of
three experiments, with the standard deviation for the exper-
iments shown in brackets. These results conﬁrm the relationship
between increased levels of RhaR and the observed metronida-
zole resistance, and demonstrate that the phenotype is not
directly dependent on the catabolism of rhamnose, but suggest
an additional as yet unknown regulatory role for the RhaR
protein in relation to metronidazole resistance.
Pyruvate oxidoreductase and lactate dehydrogenase activity
The improved growth and a metronidazole resistance pheno-
type observed in both B. thetaiotaomicron Tn Met
R and
B. thetaiotaomicron rhaR
(þ) during growth in the presence
rhamnose could be due to increased expression of RhaR affec-
ting the enzymes responsible for metronidazole activation. Given
the proposed role of pyruvate oxidoreductase in metronidazole
activation in anaerobes, and the role of lactate dehydrogenase
Figure 2. Position of IS4400L in relation to the transcriptional start site of rhaR. Nucleotide sequence of IS4400L (italics) upstream of the
B. thetaiotaomicron rhaR promoter region and nucleotide sequence; 27 and 233 promoter recognition sequences, the þ1 transcriptional start site (bold
underlined) and the ATG start codon of rhaR (bold, box) are shown. The putative 27 hexamers within the IS element are shown in bold italics and are
underlined.
38
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271in catabolism, biochemical assays were undertaken to deter-
mine the activity of the lactate dehydrogenase and pyruvate
oxidoreductase in the metronidazole-resistant strains during
growth in DMR (Table 3). The results showed that the lactate
dehydrogenase activity of B. thetaiotaomicron Tn Met
R and
B. thetaiotaomicron rhaR
(þ), during growth in DMR, was 4–5
times higher than B. thetaiotaomicron VPI-5482, whereas pyru-
vate oxidoreductase activity in these resistant strains was 7–10
times lower in comparison with the parent strain (Table 3).
These results suggested that the lower pyruvate oxidoreductase
activity observed in the resistant strains could be contributing to
the observed metronidazole resistance phenotype through a lack
of metronidazole activation.
The mechanism of metronidazole resistance in bacteria is not
well understood. However, in vitro studies have shown
that resistant strains displayed higher levels of lactate or lactate
dehydrogenase and, on occasion, no detectable levels of pyru-
vate oxidoreductase, a key enzyme that is thought to activate
metronidazole.
5 There have been no previous reports on lactate
dehydrogenase or pyruvate oxidoreductase activity in any
B. thetaiotaomicron metronidazole-resistant strains. Narikawa
et al.,
9 however, reported high levels of lactate dehydrogenase in
a B. fragilis metronidazole-resistant strain. In a more recent study,
Diniz et al.
8 studied a B. fragilis metronidazole-resistant mutant
strain, generated by exposure to a sub-lethal concentration of
metronidazole, and reported that lactate dehydrogenase activity
was up-regulated, but ﬂavodoxin was down-regulated, and there
was no detectable pyruvate oxidoreductase activity in the resist-
ant strain. They could not, however, recreate the level of metro-
nidazole resistance observed in the spontaneous mutant by
targeted genetic knock-out of either the pyruvate-ferredoxin
oxidoreductase gene (porA) or ﬂavodoxin genes. It is, therefore,
possible that during growth in rhamnose metronidazole resist-
ance in B. thetaiotaomicron Tn Met
R and B. thetaiotaomicron
rhaR
(þ) could be attributed to the lack of metronidazole acti-
vation via an altered electron ﬂux driven by the up-regulation of
rhamnose catabolism. It is possible that any mutations that give
rise to the up-regulation of catabolic pathways associated with a
concomitant decrease in pyruvate oxidoreductase activity gener-
ate metronidazole resistance within the Bacteroides spp.
The metronidazole resistance phenotype was, however, also
seen in the B. thetaiotaomicron Tn Met
R mutant cells grown in
glucose, where the products of rhamnose catabolism would not
have been a factor. While the results in the presence of rham-
nose suggested that resistance was potentially due to reduced
activation of metronidazole, the fact that the resistance
phenotype was also observed in the presence of glucose makes
this unlikely. It is, therefore, probable that the RhaR protein
encoded by the rhaR gene may also possess additional, as yet
unidentiﬁed, regulatory functions outside of the rhamnose
operon that could affect the cellular responses to metronidazole.
Xu et al.
33 analysed the B. thetaiotaomicron genome sequence
and observed that transcriptional regulatory genes, many of them
of unknown function, are particularly well represented. We have
previously reported that the RhaR protein shows conserved con-
sensus domains typical of transcriptional regulators from the
AraC helix-turn-helix (AraC/XylS) family of one-component
sensor-regulator proteins.
14 Members of the AraC family have
been characterized as being involved in regulating three types of
systems, namely pathogenesis, carbon metabolism and certain
stress responses, and in the context of regulating stress
responses, the proteins exert their regulatory role only when they
are overproduced.
34,35 We have previously shown that the reg
gene product of B. fragilis, also a member of the AraC family,
although lacking the putative cupin superfamily domain, is
involved in cell survival following exposure to several damaging
agents, including metronidazole.
36 An equivalent gene, BT
1847, is present in the B. thetaiotaomicron genome. It remains
to be determined if overexpression of the RhaR protein of
B. thetaiotaomicron Tn Met
R is functioning in a similar way to
improve cell survival in the presence of metronidazole damage
by inducing transcription of other, as yet unidentiﬁed, genes.
Future work will involve proteomic comparison of the
B. thetaiotaomicron wild-type and B. thetaiotaomicron Tn Met
R
mutant strains to identify the proteins that are up-regulated in
response to the overexpression of the RhaR protein.
This is the ﬁrst study to report a link between a carbohydrate
catabolism regulatory protein and metronidazole resistance and
presents a potentially novel mechanism for the generation of
metronidazole resistance in Bacteroides spp.
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